One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Voluntary agreements with industry: no sweet success
doi : 10.1016/S2468-1253(20)30334-4
Volume 5, Issue 12, December 2020, Page 1027
Hepatocellular carcinoma risk with antivirals for chronic hepatitis B: no longer confounding
Gregory JDoreacMarkDantabcGail VMatthewsac
Harnessing localised delivery of gut-selective therapy for ulcerative colitis
ChristopherMaabRemoPanaccionea
Gender in the endoscopy suite
Loren GallerRabinowitzaLauren TalGrinspanaMichelle KangKima
Alcohol-related liver cirrhosis in Poland: the reservoir effect
Witold AZatońskiabMateuszZatońskiacKingaJanik-KoncewiczabMartinMcKeed
Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis
Cheng-HaoTsengMDab†Yao-ChunHsuMDabcd†Tzu-HawChenMDabFanpuJiMDefI-SungChenMDabYing-NanTsaiMDabHoangHaiPhDgLe Thi ThanhThuyPhDgTetsuyaHosakaMDhHitomiSezakiMDhJohn ABorghiPhDiProfRamseyCheungMDjMasaruEnomotoMDgProfMindie HNguyenMDj
Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis
Keeley MFairbrassMBChBabSarah JCostantinoMBChBaDavid JGraciePhDab†ProfAlexander CFordMDabâ€
Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial
ProfRajaAtreyaMDabProfLaurentPeyrin-BirouletMDcdProfAndriiKlymenkoMDeMonicaAugustynMDfProfIgorBakulinMDgDusanSlankamenacMDhPalMihellerMDiProfAntonioGasbarriniMDjProfXavierHébuterneMDkKarinArnessonRNlThomasKnittelMDlJanKowalskiMScmProfMarkus FNeurathMDabProfWilliam JSandbornMDnProfWalterReinischMDoCONDUCT study group*
Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia
ProfRupaBanerjeeMDaParthaPalMDaJoyce Wing YanMakMRCPbProfSiew CNgPhDb
Optimising management strategies of inflammatory bowel disease in resource-limited settings in Asia
ProfSiew CNgPhDaJoyce Wing YanMakMRCPaParthaPalMDbProfRupaBanerjeeMDb
